Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Mounjaro vs. Ozempic: Is One More Effective For Weight Loss ...

   www.aol.com/mounjaro-vs-ozempic-better-weight...

   But there was no significant difference between the 5-milligram dose of tirzepatide and the 2-milligram dose of semaglutide. A 2021 study with almost 1,900 participants comparing their ...

3. Wegovy vs Ozempic: Is One Better for Weight Loss? - AOL

   www.aol.com/lifestyle/wegovy-ozempic-better...

   A 2017 study looked at nearly 400 participants with type 2 diabetes who took either a 0.5-milligram dose of semaglutide, a 1-milligram dose or a placebo for 30 weeks. ... Xenical (orlistat) If you ...

4. The Top 6 Ozempic Alternatives Worth Trying, According to a ...

   www.aol.com/top-6-ozempic-alternatives-worth...

   5. Liraglutide “Liraglutide is used to manage diabetes and is given as a daily shot,” Dr. Teixeira says. Similar to semaglutide, liraglutide mimics a hormone that signals insulin creation ...

5. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

6. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.

7. What Doctors Want You to Know About Ozempic and Chronic ... - AOL

   www.aol.com/doctors-want-know-ozempic-chronic...

   During a follow-up period of about 3.5 years, the researchers found that people in the semaglutide group had a 24% lower chance of having a major kidney disease event, like losing half of their ...